{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T19:08:29Z","timestamp":1790536109840,"version":"4.1.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T00:00:00Z","timestamp":1673481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T00:00:00Z","timestamp":1673481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001713","name":"European and Developing Countries Clinical Trials Partnership","doi-asserted-by":"publisher","award":["TMA2018SF-2446"],"award-info":[{"award-number":["TMA2018SF-2446"]}],"id":[{"id":"10.13039\/501100001713","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Few studies from Africa have described the clinical impact of co-infections on SARS-CoV-2 infection. Here, we investigate the presentation and outcome of SARS-CoV-2 infection in an African setting of high HIV-1 and tuberculosis prevalence by an observational case cohort of SARS-CoV-2 patients. A comparator group of non SARS-CoV-2 participants is included. The study includes 104 adults with SARS-CoV-2 infection of whom 29.8% are HIV-1 co-infected. Two or more co-morbidities are present in 57.7% of participants, including HIV-1 (30%) and active tuberculosis (14%). Amongst patients dually infected by tuberculosis and SARS-CoV-2, clinical features can be typical of either SARS-CoV-2 or tuberculosis: lymphopenia is exacerbated, and some markers of inflammation (D-dimer and ferritin) are further elevated (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). Amongst HIV-1 co-infected participants those with low CD4 percentage strata exhibit reduced total, but not neutralising, anti-SARS-CoV-2 antibodies. SARS-CoV-2 specific CD8 T cell responses are present in 35.8% participants overall but undetectable in combined HIV-1 and tuberculosis. Death occurred in 30\/104 (29%) of all COVID-19 patients and in 6\/15 (40%) of patients with coincident SARS-CoV-2 and tuberculosis. This shows that in a high incidence setting, tuberculosis is a common co-morbidity in patients admitted to hospital with COVID-19. The immune response to SARS-CoV-2 is adversely affected by co-existent HIV-1 and tuberculosis.<\/jats:p>","DOI":"10.1038\/s41467-022-35689-1","type":"journal-article","created":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T16:05:50Z","timestamp":1673539550000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Effects of tuberculosis and\/or HIV-1 infection on COVID-19 presentation and immune response in Africa"],"prefix":"10.1038","volume":"14","author":[{"given":"Elsa","family":"du Bruyn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cari","family":"Stek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remi","family":"Daroowala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qonita","family":"Said-Hartley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4926-6216","authenticated-orcid":false,"given":"Marvin","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Schafer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9818-4634","authenticated-orcid":false,"given":"Rene T.","family":"Goliath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Abrahams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Wasserman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian W.","family":"Allwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angharad G.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel P.-J.","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7086-2621","authenticated-orcid":false,"given":"Anna K.","family":"Coussens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9796-2040","authenticated-orcid":false,"given":"Katalin A.","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7192-2633","authenticated-orcid":false,"given":"Jantina","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5083-2735","authenticated-orcid":false,"given":"Nicki","family":"Tiffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6900-6086","authenticated-orcid":false,"given":"Maddalena","family":"Cerrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2347-7883","authenticated-orcid":false,"given":"Ntobeko A. B.","family":"Ntusi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"HIATUS consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatimah","family":"Abrahams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Allwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saalikha","family":"Aziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nonzwakazi","family":"Bangani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Black","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Blumenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marise","family":"Bremer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Burgers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zandile","family":"Ciko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna K.","family":"Coussens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remy","family":"Daroowala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsa","family":"du Bruyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanif G.","family":"Esmail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siamon","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolande X. R.","family":"Harley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marvin","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel P.-J.","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Lakay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando-Oneissi","family":"Martinez-Estrada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme","family":"Meintjes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc S.","family":"Mendelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ntobeko","family":"Ntusi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tari","family":"Papavarnavas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alize","family":"Proust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheena","family":"Ruzive","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Schafer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keboile","family":"Serole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Whitaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katalin A.","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kennedy","family":"Zvinairo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9679-0745","authenticated-orcid":false,"given":"Catherine","family":"Riou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2753-1800","authenticated-orcid":false,"given":"Robert J.","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,12]]},"reference":[{"key":"35689_CR1","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S1473-3099(20)30120-1","volume":"20","author":"E Dong","year":"2020","unstructured":"Dong, E., Du, H. & Gardner, L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect. Dis. 20, 533\u2013534 (2020).","journal-title":"Lancet Infect. Dis."},{"key":"35689_CR2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1126\/science.abf8832","volume":"371","author":"JM Maeda","year":"2021","unstructured":"Maeda, J. M. & Nkengasong, J. N. The puzzle of the COVID-19 pandemic in Africa. Science 371, 27\u201328 (2021).","journal-title":"Science"},{"key":"35689_CR3","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1126\/science.abe1916","volume":"371","author":"S Uyoga","year":"2021","unstructured":"Uyoga, S. et al. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Kenyan blood donors. Science 371, 79\u201382 (2021).","journal-title":"Science"},{"key":"35689_CR4","doi-asserted-by":"publisher","unstructured":"Sykes, W., et al. Prevalence of anti-SARS-CoV-2 antibodies among blood donors in Northern Cape, KwaZulu-Natal, Eastern Cape, and Free State provinces of South Africa in January 2021. Research Square, https:\/\/doi.org\/10.21203\/rs.21203.rs-233375\/v233371 (2021).","DOI":"10.21203\/rs.21203.rs-233375\/v233371"},{"key":"35689_CR5","doi-asserted-by":"publisher","first-page":"973","DOI":"10.7196\/SAMJ.2020.v110i10.15157","volume":"110","author":"M Mendelson","year":"2020","unstructured":"Mendelson, M. et al. Clinical management of COVID-19: Experiences of the COVID-19 epidemic from Groote Schuur Hospital, Cape Town, South Africa. S Afr. Med J. 110, 973\u2013981 (2020).","journal-title":"S Afr. Med J."},{"key":"35689_CR6","doi-asserted-by":"publisher","first-page":"968","DOI":"10.7196\/SAMJ.2020.v110i10.15215","volume":"110","author":"M Mendelson","year":"2020","unstructured":"Mendelson, M. et al. The mechanics of setting up a COVID-19 response: Experiences of the COVID-19 epidemic from Groote Schuur Hospital, Cape Town, South Africa. S Afr. Med J. 110, 968\u2013972 (2020).","journal-title":"S Afr. Med J."},{"key":"35689_CR7","unstructured":"Council, S.A.M.R. Report on Weekly Deaths in South Africa. https:\/\/www.samrc.ac.za\/reports\/report-weekly-deaths-south-africa."},{"key":"35689_CR8","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1093\/cid\/ciz928","volume":"71","author":"M Kubjane","year":"2020","unstructured":"Kubjane, M. et al. Tuberculosis, Human Immunodeficiency Virus, and the Association With Transient Hyperglycemia in Periurban South Africa. Clin. Infect. Dis. 71, 1080\u20131088 (2020).","journal-title":"Clin. Infect. Dis."},{"key":"35689_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-015-0750-1","volume":"15","author":"T Oni","year":"2015","unstructured":"Oni, T. et al. Patterns of HIV, TB, and non-communicable disease multi-morbidity in peri-urban South Africa- a cross sectional study. BMC Infect. Dis. 15, 20 (2015).","journal-title":"BMC Infect. Dis."},{"key":"35689_CR10","first-page":"1143","volume":"4","author":"A Boulle","year":"2019","unstructured":"Boulle, A. et al. Data Centre Profile: The Provincial Health Data Centre of the Western Cape Province, South Africa. Int J. Popul Data Sci. 4, 1143 (2019).","journal-title":"Int J. Popul Data Sci."},{"key":"35689_CR11","first-page":"ciaa1198","volume":"Aug 29","author":"A Boulle","year":"2020","unstructured":"Boulle, A. et al. Risk factors for COVID-19 death in a population cohort study from the Western Cape Province, South Africa. Clin. Infect. Dis. Aug 29, ciaa1198 (2020).","journal-title":"Clin. Infect. Dis."},{"key":"35689_CR12","doi-asserted-by":"publisher","first-page":"e554","DOI":"10.1016\/S2352-3018(21)00151-X","volume":"8","author":"W Jassat","year":"2021","unstructured":"Jassat, W. et al. Risk factors for COVID-19-related in-hospital mortality in a high HIV and tuberculosis prevalence setting in South Africa: a cohort study. Lancet HIV 8, e554\u2013e567 (2021).","journal-title":"Lancet HIV"},{"key":"35689_CR13","doi-asserted-by":"publisher","first-page":"e314","DOI":"10.1016\/S2352-3018(20)30111-9","volume":"7","author":"JL Blanco","year":"2020","unstructured":"Blanco, J. L. et al. COVID-19 in patients with HIV: clinical case series. Lancet HIV 7, e314\u2013e316 (2020).","journal-title":"Lancet HIV"},{"key":"35689_CR14","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.ijid.2020.10.060","volume":"102","author":"A Cabello","year":"2021","unstructured":"Cabello, A. et al. COVID-19 in people living with HIV: A multicenter case-series study. Int J. Infect. Dis. 102, 310\u2013315 (2021).","journal-title":"Int J. Infect. Dis."},{"key":"35689_CR15","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.1097\/QAI.0000000000002537","volume":"86","author":"L Calza","year":"2021","unstructured":"Calza, L. et al. COVID-19 Outcomes in Patients With Uncontrolled HIV-1 Infection. J. Acquir Immune Defic. Syndr. 86, e15\u2013e17 (2021).","journal-title":"J. Acquir Immune Defic. Syndr."},{"key":"35689_CR16","first-page":"1","volume":"Aug 3","author":"L Calza","year":"2020","unstructured":"Calza, L. et al. COVID-19 in patients with HIV-1 infection: a single-centre experience in northern Italy. Infection Aug 3, 1\u20135 (2020).","journal-title":"Infection"},{"key":"35689_CR17","doi-asserted-by":"crossref","unstructured":"Collins, L.F. et al. Clinical characteristics, comorbidities and outcomes among persons with HIV hospitalized with coronavirus disease 2019 in Atlanta, Georgia. AIDS 34, 1789\u20131794 (2020).","DOI":"10.1097\/QAD.0000000000002632"},{"key":"35689_CR18","first-page":"ciaa1186","volume":"Aug 17","author":"D Dandachi","year":"2020","unstructured":"Dandachi, D. et al. Characteristics, Comorbidities, and Outcomes in a Multicenter Registry of Patients with HIV and Coronavirus Disease-19. Clin. Infect. Dis. Aug 17, ciaa1186 (2020).","journal-title":"Clin. Infect. Dis."},{"key":"35689_CR19","doi-asserted-by":"publisher","first-page":"536","DOI":"10.7326\/M20-3689","volume":"173","author":"J Del Amo","year":"2020","unstructured":"Del Amo, J. et al. Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy: A Cohort Study. Ann. Intern Med 173, 536\u2013541 (2020).","journal-title":"Ann. Intern Med"},{"key":"35689_CR20","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1097\/QAI.0000000000002540","volume":"86","author":"R Hu","year":"2020","unstructured":"Hu, R. et al. Virologic and immunologic outcomes for HIV patients with coronavirus disease 2019. J. Acquir Immune Defic. Syndr. 86, 213\u2013218 (2020).","journal-title":"J. Acquir Immune Defic. Syndr."},{"key":"35689_CR21","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1097\/QAD.0000000000002643","volume":"34","author":"A Inciarte","year":"2020","unstructured":"Inciarte, A. et al. Clinical characteristics, risk factors, and incidence of symptomatic coronavirus disease 2019 in a large cohort of adults living with HIV: a single-center, prospective observational study. AIDS 34, 1775\u20131780 (2020).","journal-title":"AIDS"},{"key":"35689_CR22","unstructured":"Karim, F. et al. HIV infection alters SARS-CoV-2 responsive immune parameters but not clinical outcomes in COVID-19 disease. medRxiv, 2020.2011.2023.20236828 (2020)."},{"key":"35689_CR23","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.1093\/cid\/ciaa880","volume":"71","author":"K Sigel","year":"2020","unstructured":"Sigel, K. et al. Coronavirus 2019 and People Living With Human Immunodeficiency Virus: Outcomes for Hospitalized Patients in New York City. Clin. Infect. Dis. 71, 2933\u20132938 (2020).","journal-title":"Clin. Infect. Dis."},{"key":"35689_CR24","doi-asserted-by":"publisher","first-page":"ofab029","DOI":"10.1093\/ofid\/ofab029","volume":"8","author":"J Laracy","year":"2021","unstructured":"Laracy, J. et al. HIV-1 Infection Does Not Change Disease Course or Inflammatory Pattern of SARS-CoV-2-Infected Patients Presenting at a Large Urban Medical Center in New York City. Open Forum Infect. Dis. 8, ofab029 (2021).","journal-title":"Open Forum Infect. Dis."},{"key":"35689_CR25","doi-asserted-by":"publisher","first-page":"ofaa327","DOI":"10.1093\/ofid\/ofaa327","volume":"7","author":"K Stoeckle","year":"2020","unstructured":"Stoeckle, K. et al. COVID-19 in Hospitalized Adults With HIV. Open Forum Infect. Dis. 7, ofaa327 (2020).","journal-title":"Open Forum Infect. Dis."},{"key":"35689_CR26","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1111\/hiv.13037","volume":"22","author":"C Hoffmann","year":"2021","unstructured":"Hoffmann, C. et al. Immune deficiency is a risk factor for severe COVID-19 in people living with HIV. HIV Med 22, 372\u2013378 (2021).","journal-title":"HIV Med"},{"key":"35689_CR27","doi-asserted-by":"publisher","first-page":"e2086","DOI":"10.1093\/cid\/ciaa1186","volume":"73","author":"J Huang","year":"2021","unstructured":"Huang, J. et al. Epidemiological, virological and serological features of COVID-19 cases in people living with HIV in Wuhan City: A population-based cohort study. Clin Infect Dis. 73, e2086\u2013e2094 (2021).","journal-title":"Clin Infect Dis"},{"key":"35689_CR28","doi-asserted-by":"publisher","first-page":"e2095","DOI":"10.1093\/cid\/ciaa1605","volume":"73","author":"AM Geretti","year":"2021","unstructured":"Geretti, A. M. et al. Outcomes of Coronavirus Disease 2019 (COVID-19) Related Hospitalization Among People With Human Immunodeficiency Virus (HIV) in the ISARIC World Health Organization (WHO) Clinical Characterization Protocol (UK): A Prospective Observational Study. Clin. Infect. Dis. 73, e2095\u2013e2106 (2021).","journal-title":"Clin. Infect. Dis."},{"key":"35689_CR29","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.pulmoe.2020.05.002","volume":"26","author":"I Motta","year":"2020","unstructured":"Motta, I. et al. Tuberculosis, COVID-19 and migrants: Preliminary analysis of deaths occurring in 69 patients from two cohorts. Pulmonology 26, 233\u2013240 (2020).","journal-title":"Pulmonology"},{"key":"35689_CR30","doi-asserted-by":"publisher","first-page":"2001398","DOI":"10.1183\/13993003.01398-2020","volume":"56","author":"M Tadolini","year":"2020","unstructured":"Tadolini, M. et al. Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases. Eur. Respir. J. 56, 2001398 (2020).","journal-title":"Eur. Respir. J."},{"key":"35689_CR31","doi-asserted-by":"publisher","first-page":"2001708","DOI":"10.1183\/13993003.01708-2020","volume":"56","author":"C Stochino","year":"2020","unstructured":"Stochino, C. et al. Clinical characteristics of COVID-19 and active tuberculosis co-infection in an Italian reference hospital. Eur. Respir. J. 56, 2001708 (2020).","journal-title":"Eur. Respir. J."},{"key":"35689_CR32","doi-asserted-by":"publisher","first-page":"e938","DOI":"10.1093\/cid\/ciaa1666","volume":"72","author":"MM van der Zalm","year":"2021","unstructured":"van der Zalm, M. M. et al. Clinical experience with SARS CoV-2 related illness in children - hospital experience in Cape Town, South Africa. Clin. Infect. Dis. 72, e938\u2013e944 (2021).","journal-title":"Clin. Infect. Dis."},{"key":"35689_CR33","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1002\/jmv.26740","volume":"93","author":"S Sarkar","year":"2021","unstructured":"Sarkar, S., Khanna, P. & Singh, A. K. Impact of COVID-19 in patients with concurrent co-infections: A systematic review and meta-analyses. J. Med Virol. 93, 2385\u20132395 (2021).","journal-title":"J. Med Virol."},{"key":"35689_CR34","doi-asserted-by":"publisher","first-page":"n334","DOI":"10.1136\/bmj.n334","volume":"372","author":"L Mwananyanda","year":"2021","unstructured":"Mwananyanda, L. et al. Covid-19 deaths in Africa: prospective systematic postmortem surveillance study. BMJ 372, n334 (2021).","journal-title":"BMJ"},{"key":"35689_CR35","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s11547-020-01200-3","volume":"125","author":"A Borghesi","year":"2020","unstructured":"Borghesi, A. & Maroldi, R. COVID-19 outbreak in Italy: experimental chest X-ray scoring system for quantifying and monitoring disease progression. Radio. Med 125, 509\u2013513 (2020).","journal-title":"Radio. Med"},{"key":"35689_CR36","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.radi.2020.06.010","volume":"27","author":"BJ Stevens","year":"2021","unstructured":"Stevens, B. J. Reporting radiographers\u2019 interpretation and use of the British Society of Thoracic Imaging\u2019s coding system when reporting COVID-19 chest x-rays. Radiogr. (Lond.) 27, 90\u201394 (2021).","journal-title":"Radiogr. (Lond.)"},{"key":"35689_CR37","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1183\/09031936.00110210","volume":"36","author":"C Schutz","year":"2010","unstructured":"Schutz, C., Meintjes, G., Almajid, F., Wilkinson, R. J. & Pozniak, A. Clinical management of tuberculosis and HIV-1 co-infection. Eur. Respir. J. 36, 1460\u20131481 (2010).","journal-title":"Eur. Respir. J."},{"key":"35689_CR38","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/s41385-020-0322-6","volume":"14","author":"E Du Bruyn","year":"2021","unstructured":"Du Bruyn, E. et al. Mycobacterium tuberculosis-specific CD4 T cells expressing CD153 inversely associate with bacterial load and disease severity in human tuberculosis. Mucosal Immunol. 14, 491\u2013499 (2021).","journal-title":"Mucosal Immunol."},{"key":"35689_CR39","doi-asserted-by":"publisher","first-page":"e1176","DOI":"10.1002\/cti2.1176","volume":"9","author":"C Riou","year":"2020","unstructured":"Riou, C. et al. Disease extent and anti-tubercular treatment response correlates with Mycobacterium tuberculosis-specific CD4 T-cell phenotype regardless of HIV-1 status. Clin. Transl. Immunol. 9, e1176 (2020).","journal-title":"Clin. Transl. Immunol."},{"key":"35689_CR40","doi-asserted-by":"publisher","first-page":"e23315","DOI":"10.1097\/MD.0000000000023315","volume":"99","author":"P Ji","year":"2020","unstructured":"Ji, P. et al. Association of elevated inflammatory markers and severe COVID-19: A meta-analysis. Med. (Baltim.) 99, e23315 (2020).","journal-title":"Med. (Baltim.)"},{"key":"35689_CR41","doi-asserted-by":"publisher","first-page":"e01694","DOI":"10.1128\/JCM.01694-20","volume":"58","author":"P Muench","year":"2020","unstructured":"Muench, P. et al. Development and Validation of the Elecsys Anti-SARS-CoV-2 Immunoassay as a Highly Specific Tool for Determining Past Exposure to SARS-CoV-2. J. Clin. Microbiol 58, e01694\u201301620 (2020).","journal-title":"J. Clin. Microbiol"},{"key":"35689_CR42","doi-asserted-by":"publisher","first-page":"e149125","DOI":"10.1172\/JCI149125","volume":"131","author":"C Riou","year":"2021","unstructured":"Riou, C. et al. Relationship of SARS-CoV-2-specific CD4 response to COVID-19 severity and impact of HIV-1 and tuberculosis coinfection. J. Clin. Invest 131, e149125 (2021).","journal-title":"J. Clin. Invest"},{"key":"35689_CR43","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/s41586-020-03041-6","volume":"590","author":"K McMahan","year":"2021","unstructured":"McMahan, K. et al. Correlates of protection against SARS-CoV-2 in rhesus macaques. Nature 590, 630\u2013634 (2021).","journal-title":"Nature"},{"key":"35689_CR44","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2021.01.007","volume":"184","author":"A Sette","year":"2021","unstructured":"Sette, A. & Crotty, S. Adaptive immunity to SARS-CoV-2 and COVID-19. Cell 184, 861\u2013880 (2021).","journal-title":"Cell"},{"key":"35689_CR45","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJMoa2021436","volume":"384","author":"Recovery Collaborative Group.","year":"2021","unstructured":"Recovery Collaborative Group. et al. Dexamethasone in Hospitalized Patients with Covid-19. N. Engl. J. Med 384, 693\u2013704 (2021).","journal-title":"N. Engl. J. Med"},{"key":"35689_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26137-7","volume":"12","author":"A Alrubayyi","year":"2021","unstructured":"Alrubayyi, A. et al. Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV. Nat. Commun. 12, 5839 (2021).","journal-title":"Nat. Commun."},{"key":"35689_CR47","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1056\/NEJMoa2103055","volume":"384","author":"V Shinde","year":"2021","unstructured":"Shinde, V. et al. Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant. N. Engl. J. Med 384, 1899\u20131909 (2021).","journal-title":"N. Engl. J. Med"},{"key":"35689_CR48","unstructured":"Hwa, S. H. et al. HIV viremia is associated with compromised SARS-CoV-2 Beta variant neutralization. J Infect Dis. jiac343 (2022)."},{"key":"35689_CR49","doi-asserted-by":"publisher","first-page":"e857","DOI":"10.1093\/cid\/ciab1008","volume":"75","author":"K Khan","year":"2022","unstructured":"Khan, K. et al. Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Ad26.CoV2.S Vaccination in People Living With Human Immunodeficiency Virus (HIV). Clin. Infect. Dis. 75, e857\u2013e864 (2022).","journal-title":"Clin. Infect. Dis."},{"key":"35689_CR50","first-page":"79","volume":"72","author":"RJ Wilkinson","year":"2021","unstructured":"Wilkinson, R. J. Tuberculosis and Type 2 Diabetes Mellitus: An Inflammatory Danger Signal in the Time of Coronavirus Disease 2019. Clin. Infect. Dis. 72, 79\u201381 (2021).","journal-title":"Clin. Infect. Dis."},{"key":"35689_CR51","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris, P. A. et al. Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support. J. Biomed. Inf. 42, 377\u2013381 (2009).","journal-title":"J. Biomed. Inf."},{"key":"35689_CR52","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1126\/science.abc7520","volume":"369","author":"TF Rogers","year":"2020","unstructured":"Rogers, T. F. et al. Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model. Science 369, 956\u2013963 (2020).","journal-title":"Science"},{"key":"35689_CR53","doi-asserted-by":"crossref","unstructured":"Mou, H. et al. Mutations from bat ACE2 orthologs markedly enhance ACE2-Fc neutralization of SARS-CoV-2. bioRxiv (2020).","DOI":"10.1101\/2020.06.29.178459"},{"key":"35689_CR54","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3390\/mps1010008","volume":"1","author":"F Ferrara","year":"2018","unstructured":"Ferrara, F. & Temperton, N. Pseudotype Neutralization Assays: From Laboratory Bench to Data Analysis. Methods Protoc 1, 8 (2018).","journal-title":"Methods Protoc"},{"key":"35689_CR55","first-page":"2100285","volume":"17","author":"C Riou","year":"2021","unstructured":"Riou, C. et al. Rapid, simplified whole blood-based multiparameter assay to quantify and phenotype SARS-CoV-2 specific T cells. Eur. Respir. J., Jun. 17, 2100285 (2021).","journal-title":"Eur. Respir. J., Jun."},{"key":"35689_CR56","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.crad.2020.03.003","volume":"75","author":"JCL Rodrigues","year":"2020","unstructured":"Rodrigues, J. C. L. et al. An update on COVID-19 for the radiologist - A British society of Thoracic Imaging statement. Clin. Radio. 75, 323\u2013325 (2020).","journal-title":"Clin. Radio."},{"key":"35689_CR57","doi-asserted-by":"publisher","first-page":"e179","DOI":"10.1515\/cclm-2020-1736","volume":"59","author":"J Favresse","year":"2021","unstructured":"Favresse, J. et al. Long-term kinetics of anti-SARS-CoV-2 antibodies in a cohort of 197 hospitalized and non-hospitalized COVID-19 patients. Clin. Chem. Lab Med 59, e179\u2013e183 (2021).","journal-title":"Clin. Chem. Lab Med"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-35689-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-35689-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-35689-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T17:06:53Z","timestamp":1673543213000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-35689-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,12]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["35689"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-35689-1","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,12]]},"assertion":[{"value":"31 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors have completed the Unified Competing Interest form (available on request from the corresponding author) and declare: no financial relationships with any organisations that might have an interest in the submitted work in the previous three years, no other relationships or activities that could appear to have influenced the submitted work.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"188"}}